FRED HUTCHINSON CANCER CENTER
Selective Depletion of CD45RA+ T Cells From Allogeneic Peripheral Blood Stem Cell Grafts From HLA-Matched Related and Unrelated Donors in Preventing GVHD
- Conditions
- Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 PositiveDonorRecurrent Acute Lymphoblastic LeukemiaRefractory Acute Myeloid LeukemiaChildhood Acute Myeloid Leukemia in RemissionMyelodysplastic Syndrome With Excess Blasts-2Recurrent Childhood Acute Lymphoblastic LeukemiaRecurrent Childhood Acute Myeloid LeukemiaRecurrent Chronic Myelogenous Leukemia, BCR-ABL1 PositiveAcute Biphenotypic Leukemia
- Interventions
- Procedure: Allogeneic Hematopoietic Stem Cell TransplantationDrug: CyclophosphamideDrug: Fludarabine PhosphateOther: Laboratory Biomarker AnalysisDrug: Mycophenolate MofetilDrug: MethotrexateProcedure: Peripheral Blood Stem Cell TransplantationDrug: TacrolimusDrug: ThiotepaRadiation: Total-Body Irradiation
- First Posted Date
- 2014-08-20
- Last Posted Date
- 2024-08-19
- Lead Sponsor
- Fred Hutchinson Cancer Center
- Target Recruit Count
- 84
- Registration Number
- NCT02220985
- Locations
- 🇺🇸
University of Pittsburgh Cancer Institute (UPCI), Pittsburgh, Pennsylvania, United States
🇺🇸Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington, United States
Survivorship Care in Reducing Symptoms in Young Adult Cancer Survivors
- Conditions
- Interventions
- First Posted Date
- 2014-07-16
- Last Posted Date
- 2020-10-09
- Lead Sponsor
- Fred Hutchinson Cancer Center
- Target Recruit Count
- 390
- Registration Number
- NCT02192333
- Locations
- 🇺🇸
Dana-Farber Cancer Institute, Boston, Massachusetts, United States
🇺🇸UCLA / Jonsson Comprehensive Cancer Center, Los Angeles, California, United States
🇺🇸UNC Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina, United States
TLR4 Agonist GLA-SE and Radiation Therapy in Treating Patients With Soft Tissue Sarcoma That Is Metastatic or Cannot Be Removed by Surgery
- First Posted Date
- 2014-07-03
- Last Posted Date
- 2019-11-06
- Lead Sponsor
- Fred Hutchinson Cancer Center
- Target Recruit Count
- 16
- Registration Number
- NCT02180698
- Locations
- 🇺🇸
Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington, United States
Tocilizumab for Chronic Graft-versus-Host Disease Treatment
- Conditions
- Interventions
- First Posted Date
- 2014-06-25
- Last Posted Date
- 2016-05-06
- Lead Sponsor
- Fred Hutchinson Cancer Center
- Registration Number
- NCT02174263
- Locations
- 🇺🇸
Vanderbilt-Ingram Cancer Center, Nashville, Tennessee, United States
🇺🇸Medical College of Wisconsin, Milwaukee, Wisconsin, United States
🇺🇸Mayo Clinic, Rochester, Minnesota, United States
Malaria Clinical Trials Center General Screening
- Conditions
- First Posted Date
- 2014-04-21
- Last Posted Date
- 2020-09-14
- Lead Sponsor
- Fred Hutchinson Cancer Center
- Target Recruit Count
- 2101
- Registration Number
- NCT02119312
- Locations
- 🇺🇸
Fred Hutchinson Cancer Research Center, Seattle, Washington, United States
NY-ESO-1 Specific T Cells After Cyclophosphamide in Treating Patients With Advanced Synovial Sarcoma or Myxoid/Round Cell Liposarcoma
- Conditions
- Interventions
- First Posted Date
- 2014-02-11
- Last Posted Date
- 2016-02-03
- Lead Sponsor
- Fred Hutchinson Cancer Center
- Registration Number
- NCT02059850
- Locations
- 🇺🇸
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium, Seattle, Washington, United States
Filgrastim, Cladribine, Cytarabine, and Mitoxantrone Hydrochloride in Treating Patients With Newly Diagnosed or Relapsed/Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndromes
- Conditions
- Interventions
- First Posted Date
- 2014-01-24
- Last Posted Date
- 2020-01-10
- Lead Sponsor
- Fred Hutchinson Cancer Center
- Target Recruit Count
- 199
- Registration Number
- NCT02044796
- Locations
- 🇺🇸
Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington, United States
Screening Mammography and Latinas: A Multilevel Intervention
- Conditions
- Interventions
- First Posted Date
- 2013-12-12
- Last Posted Date
- 2015-07-02
- Lead Sponsor
- Fred Hutchinson Cancer Center
- Target Recruit Count
- 540
- Registration Number
- NCT02010008
- Locations
- 🇺🇸
Fred Hutchinson Cancer Research Center, Seattle, Washington, United States
Epacadostat and Vaccine Therapy in Treating Patients With Stage III-IV Melanoma
- Conditions
- Interventions
- First Posted Date
- 2013-10-11
- Last Posted Date
- 2018-06-08
- Lead Sponsor
- Fred Hutchinson Cancer Center
- Target Recruit Count
- 11
- Registration Number
- NCT01961115
- Locations
- 🇺🇸
Cleveland Clinic Foundation, Cleveland, Ohio, United States
🇺🇸Duke University Medical Center, Durham, North Carolina, United States
🇺🇸University of Virginia Cancer Center, Charlottesville, Virginia, United States
Recombinant Interferon Gamma in Treating Patients With Soft Tissue Sarcoma
- Conditions
- Interventions
- First Posted Date
- 2013-10-08
- Last Posted Date
- 2019-07-10
- Lead Sponsor
- Fred Hutchinson Cancer Center
- Target Recruit Count
- 8
- Registration Number
- NCT01957709
- Locations
- 🇺🇸
Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington, United States